Subscribe
Sign in
Home
Work with us / Advertise
CensHERship
Archive
About
Latest
Top
Discussions
💌 PCOS to rename | Sub-Q Bionic raises $1.5m for lymphedema | egg freezing cost guarantees | 'sandwich generation support'
The global weekly briefing on women's health innovation and Femtech
2 hrs ago
•
Anna O'Sullivan
17
The PCOS opportunity: a deep dive into this unsolved area of women’s health
No cure, a thin pharmaceutical pipeline and huge unmet need. Here are the innovators solving for this space.
4 hrs ago
•
Anna O'Sullivan
3
Women’s Health Week USA 2026: what to expect at the sector’s most commercially-focused gathering
We're entering the era of scale.
4 hrs ago
•
Anna O'Sullivan
💌 Issue 140: WHOOP raises $575m as Garmin moves into care | IVF crosses into genetic selection | The real bottleneck in women’s health
The global weekly briefing on women's health innovation and Femtech
Apr 1
•
Anna O'Sullivan
22
2
1
March 2026
myStoria raises $1.625M seed round and expands reproductive health platform
Vision is to create a health partner for life
Mar 31
•
Anna O'Sullivan
1
What the African femtech market is really telling us
A mismatch between the products being built, the evidence behind them and where investment is flowing
Mar 31
•
Anna O'Sullivan
What happens when investors dismiss women's health - before companies even exist?
A firsthand account from inside a student pitch competition
Mar 31
•
Anna O'Sullivan
6
3
2
Prickly Pear Health expands pre-seed funding to $600k as it builds a brain health layer for women
Arizona is the launchpad
Mar 28
•
Anna O'Sullivan
1
💌 Issue 139: The $600bn women's health market | global health index | Endometrics awarded nearly $1m | new chronic pain treatment
The global weekly briefing on women's health innovation and Femtech
Mar 25
•
Anna O'Sullivan
8
2
1
The moment doula care became investable
As Medicaid expands coverage and outcomes become measurable, a once-marginal support role is emerging as a scalable, payer-backed care model
Mar 23
•
Anna O'Sullivan
2
1
EndoCyclic Therapeutics advances non-hormonal endometriosis drug into clinical trials
Will begin human trials following US regulatory clearance
Mar 23
•
Anna O'Sullivan
3
Maven Clinic launches AI system to guide patients through care - not just provide support
New “Maven Intelligence” layer uses patient data to flag risks, suggest next steps and coordinate care across fertility, pregnancy and menopause
Mar 21
•
Anna O'Sullivan
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts
